Espen Molden om bedre behandlingseffekt med psykofarmakologiske gentester

NO-BRIN-0090-2020.02

Referanser

1. Jukic MM, Haslemo T, Molden E et al. Impact of CYP2C19 Genotype on Escitalopram Exposure and Therapeutic Failure: A Retrospective Study Based on 2,087 Patients. Am J Psychiatr 2018;175(5):463-70.

2. Jukic MM, Smith RL, Haslemo T et al. Effect of CYP2D6 Genotype on Exposure and Efficacy of Risperidone and Aripiprazole: A Retrospective, Cohort Study. Lancet Psychiatry 2019;6(5):418-26.

3. Crawford AA, Lewis G, Lewis SJ et al. Systematic review and meta-analysis of serotonin transporter genotype and discontinuation from antidepressant treatment. Eur Neuropsychopharmacol 2013;23(10): 1143–50.

4. Forskning og innovasjon til pasientens beste. Nasjonal rapport fra spesialisthelsetjenesten 2017. Side 6-7. https://www.helse-sorost.no/Documents/Forskning/Nasjonal%20Forskningsrapport%202017.pdf

Du forlater Progress in Mind
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
Informasjonen på dette nettstedet er utelukkende ment for helsepersonell
Congress
Register for access to Progress in Mind in your country